• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

byConstance Wu
April 18, 2020
in StudyGraphics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

The Scan by 2 Minute Medicine®: The Fight Against Childhood Obesity, Prioritizing Mental Health, The Rise of XBB1.5, and Choose Your Chocolates Wisely

Time-restricted eating ineffective for weight loss

2 Minute Medicine Rewind January 23, 2023

1. The combination of liraglutide and lifestyle therapy was shown to significantly reduce body mass index (BMI) standard-deviation score compared to the placebo group.

2. The use of liraglutide as adjuvant therapy was shown to cause a higher frequency of gastrointestinal adverse events.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Obesity is a chronic and progressive disease with few treatment options for the pediatric patient population. The first-line treatment is lifestyle therapy, which has yielded poor results, and bariatric surgery is seldom performed within this patient population. Pharmacologically, only orlistat and phentermine have been approved by the Food and Drug Administration. As such, liraglutide presents another treatment option in combination with lifestyle therapy for adolescents where obesity is of concern. The study evaluated the efficacy and safety of subcutaneous liraglutide in combination with lifestyle therapy for weight management in adolescents with obesity. All participants received lifestyle therapy and were randomized to receive liraglutide or placebo. The study found the addition of liraglutide with lifestyle therapy led to a greater reduction in the BMI standard-deviation score, a relative measure of BMI adjusted for age and sex, compared to the placebo group. However, the participants in the liraglutide group presented with a higher frequency of gastrointestinal adverse effects compared to the placebo group.

This randomized, double-blind, phase 3, trial was limited by the lack of cardiometabolic profiling conducted throughout the study as secondary outcomes. Since a major concern of childhood obesity surrounds cardiovascular outcomes, cardiometabolic profiling may have elucidated the effect of liraglutide treatment on cardiac health. Nonetheless, this study was strengthened by the high retention rate and evenly matched sample size. For physicians, these findings highlighted an alternative therapy to be prescribed to pediatric patients to complement the weight management through lifestyle therapy.

Click to read the study in NEJM

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: BMIliraglutideobesityweight loss
Previous Post

Decreased risk of ovarian cancer in women who have breastfed

Next Post

SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: The Fight Against Childhood Obesity, Prioritizing Mental Health, The Rise of XBB1.5, and Choose Your Chocolates Wisely

January 25, 2023
Sleep duration inversely related to childhood type 2 diabetes risk makers
Cardiology

Time-restricted eating ineffective for weight loss

January 23, 2023
Many new pediatric asthma cases attributable to obesity
Weekly Rewinds

2 Minute Medicine Rewind January 23, 2023

January 23, 2023
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Chronic Disease

Weekly semaglutide associated with reduced BMI in adolescents with obesity

December 26, 2022
Next Post
SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant

SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant

Classics Series, Landmark Trials in Medicine

The POISE trial: Perioperative use of beta-blockers [Classics Series]

#VisualAbstract: Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

#VisualAbstract: Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher body mass index may be associated with altered vitamin D levels and metabolism
  • #VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
  • Community-based adult vision screening program increases access to eye care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options